Zobrazeno 1 - 8
of 8
pro vyhledávání: '"P H, Juergensen"'
Publikováno v:
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis. 20(6)
The Dialysis Outcomes Quality Initiative (DOQI) guidelines, published in 1997, emphasize the need for careful monitoring of iron stores and for provision of adequate iron replacement therapy to achieve target goals of hemoglobin concentration in end-
Publikováno v:
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis. 15
Patients with end-stage renal disease on chronic peritoneal dialysis (CPD) can usually tolerate continuous ambulatory peritoneal dialysis (CAPD) or continuous cycling peritoneal dialysis (CCPD) without abdominal discomfort or pain. In some patients,
Publikováno v:
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis. 14
Presently, adequate dialysis in continuous peritoneal dialysis (CPD) patients is assessed by monitoring urea kinetics (Kt/V) or by measuring the total creatinine clearance (CC). Target Dialysis Outcome Quality Initiative (DOQI) goals are a weekly Kt/
Publikováno v:
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis. 14
Hyperparathyroidism (HPT) is a common finding in patients with end-stage renal disease (ESRD). Most chronic peritoneal dialysis (CPD) patients with HTP can be successfully managed with phosphate binders, calcium supplements, and calcitriol therapy. N
Autor:
P H, Juergensen, D B, Wuerth, D M, Juergensen, S H, Finkelstein, T E, Steele, A S, Kliger, F O, Finkelstein
Publikováno v:
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis. 13
Patient dropout from chronic peritoneal dialysis (CPD) and transfer to hemodialysis remains a major problem with patients on CPD. Peritonitis, exit-site infections, and medical complications requiring hospitalization often adversely affect the outcom
Autor:
D B, Wuerth, S H, Finkelstein, D M, Juergensen, P H, Juergensen, T E, Steele, A S, Kliger, F O, Finkelstein
Publikováno v:
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis. 13
Previous studies by our group have attempted to examine quality of life (QoL) issues in a cohort of end-stage renal disease (ESRD) patients maintained on chronic peritoneal dialysis (CPD) by assessing a variety of psychological tests and by asking pa
Autor:
P H, Juergensen, D M, Juergensen, D B, Wuerth, S H, Finkelstein, T E, Steele, A S, Kliger, F O, Finkelstein
Publikováno v:
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis. 12
It has been suggested that psychosocial (PS) factors may influence morbidity and mortality in chronically ill patients. However, investigators have not examined how PS factors affect specific medical problems in chronic peritoneal dialysis (CPD) pati
Publikováno v:
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis. 9
Hyperparathyroidism remains a cause of significant morbidity in dialysis patients. We studied pulse oral calcitriol, 5.0 micrograms biweekly to control hyperparathyroidism in 12 continuous ambulatory peritoneal dialysis (CAPD) patients. Parathyroid h